Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:OASM

Oasmia Pharmaceutical AB (publ) (OASM) Stock Price, News & Analysis

→ Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad)
Free OASM Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.05
▼
$0.05
50-Day Range
$1.30
▼
$1.62
52-Week Range
$0.94
▼
$5.70
Volume
N/A
Average Volume
98,414 shs
Market Capitalization
$3.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsHeadlinesSocial Media

About Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

OASM Stock News Headlines

May 17 at 7:52 PM | newsweek.com
Sector-Health Care & Pharmaceuticals
April 30, 2024 | seekingalpha.com
BOEUF Bonesupport Holding AB (publ)
March 23, 2024 | morningstar.com
Lipigon Pharmaceuticals AB LPGO
March 6, 2024 | gurufocus.com
LSK BioPartners, Inc., Oasmia Pharmaceutical AB (publ) - Special Call Transcript
March 6, 2024 | gurufocus.com
Oasmia Pharmaceutical AB (publ) - Special Call Transcript
February 8, 2024 | finance.yahoo.com
Resurs Holding AB (publ) (RESURS.ST)
January 6, 2024 | morningstar.com
QuiaPEG Pharmaceuticals Holding AB QUIA
November 29, 2023 | investing.com
Newbury Pharmaceuticals AB (NEWBRY)
September 14, 2023 | investing.com
Lipigon Pharmaceuticals AB (LPGO)
August 25, 2023 | investing.com
Speqta publ AB (SPEQT)
August 25, 2023 | seekingalpha.com
PRXXF Paradox Interactive AB (publ)
February 26, 2023 | seekingalpha.com
OXE Marine AB (publ) Non-GAAP EPS of -SEK0.43, revenue of SEK32.2M
March 11, 2022 | stockhouse.com
Orexo appoints Fredrik Järrsten as new CFO
November 29, 2021 | finanznachrichten.de
Notice of extra general meeting in Terranet AB
July 22, 2021 | investing.com
Fancy Wood Industries PCL (FANCY)
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OASM
CUSIP
N/A
CIK
1607245
Web
www.oasmia.com
Phone
(461) 850-5440
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-18,950,000.00
Net Margins
-8,633.64%
Pretax Margin
N/A
Return on Equity
-43.94%
Return on Assets
-28.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.80
Quick Ratio
0.73

Sales & Book Value

Annual Sales
$220,000.00
Price / Sales
17.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.63 per share
Price / Book
0.08

Miscellaneous

Outstanding Shares
74,967,000
Free Float
N/A
Market Cap
$3.74 million
Optionable
Not Optionable
Beta
0.96

Key Executives

  • François R. Martelet
    Chief Executive Officer
  • Fredrik Järrsten
    Chief Financial Officer
  • Mikael Asp
    Chief Technology Officer
  • Nigel Goodman
    Director-Clinical Operations
  • Carina Eklöw
    Director-Global Medical Affairs

Key Competitors

View All Competitors

OASM Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Oasmia Pharmaceutical AB (publ) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oasmia Pharmaceutical AB (publ) investors own include G1 Therapeutics (GTHX), Amarin (AMRN), CRISPR Therapeutics (CRSP), Supernus Pharmaceuticals (SUPN), Verastem (VSTM), Akari Therapeutics (AKTX), Nightstar Therapeutics (NITE), Novavax (NVAX) and OpGen (OPGN).

This page (NASDAQ:OASM) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Does this make you sick?
Allegiance Gold
Dems have chosen Biden replacement?
Paradigm Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest